 |
|
|
| |
The effect of sofosbuvir containing regimens in patients with HCV
genotype 3 - A Scandinavian real-life experience. [effect of cirrhosis/CP-A/B/C
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Olav Dalgard* 1, Ola Weiland2, Geir Noraberg3, Lars Karlsen4, Martin Lagging5, Lars Heggelund6, Martti Farkkila7, Nina Weiss8, Ulla Balslev9, Erika Belard9, Anne L.h. ovrehus9, 10, Mette S. Kjaer11, Henrik Krarup12, Birgit T Roege13, Sofie Hallager14, Lone Madsen15, Nina M Weiss16
1Infectious disease department, Akershus University Hospital, Lorenskog, Norway, 2Infectious disease department, Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden, 3Dept of gastroenterology, Sorlandet sykehus, Arendal, Arendal, 4Dept of gastroenterology, Stavanger University Hospital, Stavanger, Norway, 5Department of Infectious Medicine / Virology , Sahlgrenska Academy, University of Gothenburg, Gothenborg, Sweden, 6Infectious disease department, Vestre Viken HF-Drammen, Drammen, Norway, 7Gastroenenterology, Helsinki University Hospital, Helsinki, Finland, 8 Department of Infectious Diseases, , Hvidovre Hospital, University of Copenhagen, , 9Medical dept, Copenhagen University Hospital, Herlev, Copenhagen, 10Infectious Disase Department, Odense University Hospital, Odense, 11Dept of Hepatology, Copenhagen university Hospital, Rigshospitalet, Copenhagen, 12Dept of gastroenterology, Aalborg University Hospital, Aalborg, 13Department of Infectious Diseases,, Kolding Hospital, Kolding, 14 Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, 15Department of Gastroenterology, Koge Hospital, Koge, 16Infectious Disease Department, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark
|
| |
|
|
|
|
|
